Company intelligence / Profile preview
Yash Pharma Laboratories
- Ownership
- Private
- Employees
- ~521
- Development stage
- Other
Overview
Yash Pharma Laboratories manufactures and exports a wide range of generic finished dose pharmaceutical products, focusing mainly on dermatology and also covering respiratory, anti-fungal, anti-emetic, and ophthalmic indications. The company does not conduct its own clinical trials and is not developing NCEs, and its portfolio consists of established drugs available in India and global markets.[1][6]
- Therapeutic areas
- OphthalmologyInfectious DiseasesGastroenterologyDermatologyPulmonology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Yash Pharma Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yash Pharma Laboratories.